{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:47:27Z","timestamp":1782978447098,"version":"3.54.5"},"reference-count":61,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Int"],"DOI":"10.3892\/mi.2026.319","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:36:05Z","timestamp":1778052965000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Systemic lupus erythematosus in pregnancy: Maternal and fetal outcomes and management strategies (Review)"],"prefix":"10.3892","volume":"6","author":[{"given":"Isra","family":"Omar","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, College of Medicine, Almaarefa University, Riyadh 11597, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alakhras","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, College of Medicine, Almaarefa University, Riyadh 11597, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, College of Medicine, Almaarefa University, Riyadh 11597, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samahir","family":"Mutwali","sequence":"additional","affiliation":[{"name":"TeleGeriatric Michigan State University Fellowship Program, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"key20260702095021_b1-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/OARRR.S87828","article-title":"Management of systemic lupus erythematosus during pregnancy: Challenges and solutions","volume":"8","author":"Knight","year":"2016","journal-title":"Open Access Rheumatol"},{"key":"key20260702095021_b2-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front Neuroendocr"},{"key":"key20260702095021_b3-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bpobgyn.2019.09.002","article-title":"Pregnancy and systemic lupus erythematosus","volume":"64","author":"Petri","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key20260702095021_b4-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1016\/S2665-9913(24)00160-7","article-title":"Pregnancy outcome predictors in systemic lupus erythematosus: A systematic review and meta-analysis","volume":"6","author":"Wind","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"key20260702095021_b5-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"B41","DOI":"10.1016\/j.ajog.2022.09.001","article-title":"Society for maternal-fetal medicine consult series #64: Systemic lupus erythematosus in pregnancy","volume":"228","author":"Silver","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"e000651","key":"key20260702095021_b6-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000651","article-title":"Hydroxychloroquine in the pregnancies of women with lupus: A meta-analysis of individual participant data","volume":"9","author":"Clowse","year":"2022","journal-title":"Lupus Sci Med"},{"issue":"3454","key":"key20260702095021_b7-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123454","article-title":"Modern management of pregnancy in systemic lupus erythematosus: From prenatal counseling to postpartum support","volume":"13","author":"Gamba","year":"2024","journal-title":"J Clin Med"},{"key":"key20260702095021_b8-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology guideline for reproductive health in rheumatic diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"key20260702095021_b9-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/IJWH.S282604","article-title":"Systemic lupus erythematosus management in pregnancy","volume":"14","author":"Dao","year":"2022","journal-title":"Int J Womens Health"},{"key":"key20260702095021_b10-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"key20260702095021_b11-MI-6-4-00319","author":"Rubin"},{"issue":"906475","key":"key20260702095021_b12-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.906475","article-title":"Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus","volume":"9","author":"Kim","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"key20260702095021_b13-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update on the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"103259","key":"key20260702095021_b14-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103259","article-title":"Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases","volume":"22","author":"Andreoli","year":"2023","journal-title":"Autoimmun Rev"},{"key":"key20260702095021_b15-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/art.42756","article-title":"Expert perspective on a clinical challenge: Lupus and pregnancy","volume":"76","author":"Tarter","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"key20260702095021_b16-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3899\/jrheum.200802","article-title":"Lupus low disease activity state achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus","volume":"48","author":"Kim","year":"2021","journal-title":"J Rheumatol"},{"key":"key20260702095021_b17-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1093\/rheumatology\/keab155","article-title":"Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study","volume":"60","author":"Tani","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"660123","key":"key20260702095021_b18-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.660123","article-title":"SLE-DAS in the first trimester of gestation predicts maternal lupus flares later in pregnancy","volume":"12","author":"Larosa","year":"2021","journal-title":"Front Pharmacol"},{"key":"key20260702095021_b19-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00404-021-06148-x","article-title":"Maternal disease activity and serological activity as predictors of adverse pregnancy outcomes in women with systemic lupus erythematosus: A retrospective chart review","volume":"305","author":"Murata","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"key20260702095021_b20-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1177\/09612033231216602","article-title":"The impact of pregnancy planning and medical readiness on reproductive outcomes in women with systemic lupus erythematosus","volume":"32","author":"Sims","year":"2023","journal-title":"Lupus"},{"key":"key20260702095021_b21-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3899\/jrheum.171023","article-title":"Monitoring of systemic lupus erythematosus pregnancies: A systematic literature review","volume":"45","author":"McDonald","year":"2028","journal-title":"J Rheumatol"},{"key":"key20260702095021_b22-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"38","DOI":"10.18502\/jfrh.v15i1.6076","article-title":"Evaluation of the ovarian reserve in women with systemic lupus erythematosus","volume":"15","author":"Morales-Martinez","year":"2021","journal-title":"J Fam Reprod Health"},{"key":"key20260702095021_b23-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1177\/09612033221128740","article-title":"Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: A meta-analysis","volume":"31","author":"Ejaz","year":"2022","journal-title":"Lupus"},{"key":"key20260702095021_b24-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"key20260702095021_b25-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"issue":"e000840","key":"key20260702095021_b26-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000840","article-title":"Infertility in systemic lupus erythematosus: What rheumatologists need to know in a new age of assisted reproductive technology","volume":"9","author":"Stamm","year":"2022","journal-title":"Lupus Sci Med"},{"key":"key20260702095021_b27-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1055\/s-0044-1793827","article-title":"Impact of systemic lupus erythematosus on conception: Insights into infertility, fertility preservation, assisted reproductive technology, and pregnancy outcomes","volume":"42","author":"Moyer","year":"2024","journal-title":"Semin Reprod Med"},{"key":"key20260702095021_b28-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/acr.24360","article-title":"Soluble Flt-1, placental growth factor, and vascular endothelial growth factor serum levels to differentiate between active lupus nephritis during pregnancy and preeclampsia","volume":"73","author":"de Jesus","year":"2021","journal-title":"Arthritis Care Res Hoboken"},{"key":"key20260702095021_b29-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13730-018-0373-7","article-title":"Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy","volume":"8","author":"Hirashima","year":"2019","journal-title":"CEN Case Rep"},{"key":"key20260702095021_b30-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2023.12.039","article-title":"Calcineurin inhibitors in the treatment of systemic lupus erythematosus during pregnancy: A narrative review with emphasis on efficacy and safety","volume":"294","author":"Jiang","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9281","key":"key20260702095021_b31-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179281","article-title":"An overview of neonatal lupus with anti-Ro characteristics","volume":"22","author":"Gryka-Marton","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20260702095021_b32-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1590\/s0001-37652000000100012","article-title":"Neonatal lupus syndrome: The heart as a target of the immune system","volume":"72","author":"Garcia","year":"2007","journal-title":"Acad Bras Cienc"},{"key":"key20260702095021_b33-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"key20260702095021_b34-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/09612033211004716","article-title":"The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus","volume":"28","author":"Bremme","year":"2019","journal-title":"Lupus"},{"key":"key20260702095021_b35-MI-6-4-00319","author":"Moroni"},{"key":"key20260702095021_b36-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/1744666X.2024.2324005","article-title":"Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: A systematic review and meta-analysis","volume":"20","author":"Huang","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"key20260702095021_b37-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"key20260702095021_b38-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"key":"key20260702095021_b39-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"51","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"e000131","key":"key20260702095021_b40-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: Validation of PROMISSE study results","volume":"3","author":"Yelnik","year":"2016","journal-title":"Lupus Sci Med"},{"key":"key20260702095021_b41-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","article-title":"The placental bed in pregnancies complicated by primary antiphospholipid syndrome","volume":"27","author":"Stone","year":"2006","journal-title":"Placenta"},{"issue":"5224","key":"key20260702095021_b42-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105224","article-title":"Molecular mechanisms of fetal and neonatal lupus: A narrative review of an autoimmune disease transferal across the placenta","volume":"25","author":"Di Ludovico","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"301274","key":"key20260702095021_b43-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/301274","article-title":"Neonatal lupus erythematosus","volume":"2012","author":"Lun Hon","year":"2012","journal-title":"Autoimmune Dis"},{"key":"key20260702095021_b44-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key20260702095021_b45-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/IJWH.S90157","article-title":"Systemic lupus erythematosus: Strategies to improve pregnancy outcomes","volume":"8","author":"Yamamoto","year":"2016","journal-title":"Int J Womens Health"},{"key":"key20260702095021_b46-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key20260702095021_b47-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/humupd\/dmv047","article-title":"The clinical use of corticosteroids in pregnancy","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum Reprod Update"},{"key":"key20260702095021_b48-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.rdc.2016.12.009","article-title":"Systemic lupus erythematosus and pregnancy","volume":"43","author":"Lateef","year":"2017","journal-title":"Rheum Clin North Am"},{"key":"key20260702095021_b49-MI-6-4-00319","author":"US"},{"key":"key20260702095021_b50-MI-6-4-00319","first-page":"41","article-title":"Antiphospholipid syndrome during pregnancy: The state of the art","volume":"5","author":"Di Prima","year":"2011","journal-title":"J Prenat Med"},{"key":"key20260702095021_b51-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0049-3848(19)30366-4","article-title":"Managing antiphospholipid syndrome in pregnancy","volume":"181 (Suppl 1)","author":"Schreiber","year":"2019","journal-title":"Thromb Res"},{"key":"key20260702095021_b52-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5493\/wjem.v13.i4.99","article-title":"Update on hydroxychloroquine use in pregnancy","volume":"13","author":"Nori","year":"2023","journal-title":"World J Exp Med"},{"issue":"485","key":"key20260702095021_b53-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020485","article-title":"Effect of hydroxychloroquine on lupus activity, preeclampsia and intrauterine growth restriction in pregnant women with systemic lupus erythematosus and\/or antiphospholipid syndrome: A systematic review and meta-analysis","volume":"12","author":"Hu","year":"2023","journal-title":"J Clin Med"},{"key":"key20260702095021_b54-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/09612033211007199","article-title":"Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis","volume":"30","author":"Duan","year":"2021","journal-title":"Lupus"},{"key":"key20260702095021_b55-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1046\/j.1365-2036.2003.01537.x","article-title":"Azathioprine, mercaptopurine and birth outcome: A population-based cohort study","volume":"17","author":"N\u00f8rg\u00e5rd","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"key20260702095021_b56-MI-6-4-00319","first-page":"1401","article-title":"Safety of azathioprine use during pregnancy","volume":"57","author":"Natekar","year":"2011","journal-title":"Can Fam Physician"},{"key":"key20260702095021_b57-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejmg.2016.09.014","article-title":"Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome","volume":"61","author":"Perez-Aytes","year":"2017","journal-title":"Eur J Med Genet"},{"key":"key20260702095021_b58-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.reprotox.2009.02.007","article-title":"Tetrada of the possible mycophenolate mofetil embryopathy: A review","volume":"28","author":"Merlob","year":"2009","journal-title":"Reprod Toxicol"},{"key":"key20260702095021_b59-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/ajmg.a.32715","article-title":"Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: Possible teratogenic effect","volume":"149A","author":"Jackson","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"e001239","key":"key20260702095021_b60-MI-6-4-00319","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001239","article-title":"Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: A systematic review and meta-analysis","volume":"11","author":"Zhu","year":"2024","journal-title":"Lupus Sci Med"},{"key":"key20260702095021_b61-MI-6-4-00319","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"}],"container-title":["Medicine International"],"original-title":[],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:50:27Z","timestamp":1782975027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mi.2026.319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.3892\/mi.2026.319","relation":{},"ISSN":["2754-3242","2754-1304"],"issn-type":[{"value":"2754-3242","type":"print"},{"value":"2754-1304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}